Inventor profile of:

Yaron Ilan

City:

Jerusalem

Country:

Israel

Published Applications:

54

Last publication date:

2021-08-26

Top Assignees for applications by Yaron Ilan

The entities that hold a legal rights for patent applications filed by inventor Ilan Yaron:

Recent patent applications by Ilan Yaron

Yaron Ilan from Jerusalem, IL has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2021-08-26
US20210260100A1
Human necessities

GLUCOCEREBROSIDE TREATMENT OF DISEASE

#2 | 2021-04-08
US20210100493A1
Human necessities

BREATH TEST DEVICE AND METHOD

#3 | 2020-09-10
US20200281961A1
Human necessities

GLUCOCEREBROSIDE TREATMENT OF DISEASE

#4 | 2019-07-11
US20190209681A1
Human necessities

Anti-LPS Enriched Immunoglobulin Preparation for Use in the Treatment and/or Prophylaxis of a Pathologic Disorder

#5 | 2019-02-28
US20190060353A1
Human necessities

Glucocerebroside treatment of disease

#6 | 2019-01-03
US20190000854A1
Human necessities

Treatment of non-alcoholic fatty liver disease or non-alcoholic steatohepatitis with delayed-release 6-mercaptopurine

#7 | 2018-02-15
US20180042959A1
Human necessities

GLUCOCEREBROSIDE TREATMENT OF DISEASE

#8 | 2018-02-15
US20180042951A1
Human necessities

Glucocerebroside treatment of liver disorders

#9 | 2018-02-08
US20180036326A1
Human necessities

METHOD FOR TREATING HIV

#10 | 2017-08-01
US10675980
Human necessities

Glucocerebroside treatment of disease

#11 | 2017-04-20
US20170105996A1
Human necessities

TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE OR NON-ALCOHOLIC STEATOHEPATITIS WITH DELAYED-RELEASE 6-MERCAPTOPURINE

#12 | 2017-02-16
US20170042921A1
Human necessities

METHOD FOR TREATING HIV

#13 | 2016-09-01
US20160251414A1
Chemistry; metallurgy

Anti-LPS enriched immunoglobulin for use in treatment and/or prophylaxis of fibrosis

#14 | 2016-07-14
US20160199362A1
Human necessities

METHOD FOR THE TREATMENT, ALLEVIATION OF SYMPTOMS OF, RELIEVING, IMPROVING AND PREVENTING A COGNITIVE DISEASE, DISORDER OR CONDITION

#15 | 2016-01-07
US20160002312A1
Chemistry; metallurgy

Methods for treating or reducing liver diseases by administering oral composition comprising TNF receptor fusion proteins

#16 | 2015-07-30
US20150209338A1
Human necessities

Method for decreasing symptoms of alcohol consumption

#17 | 2015-05-14
US20150132289A1
Chemistry; metallurgy

METHODS AND COMPOSITIONS FOR TREATING PSC (PRIMARY SCLEROSING CHOLANGITIS) OR PBC (PRIMARY BILIARY CIRRHOSIS) WITH ANTI-CD3 IMMUNE MOLECULE THERAPY

#18 | 2015-03-19
US20150080348A1
Human necessities

Compositions and methods for amelioration and prevention of drug-induced toxicity

#19 | 2014-11-20
US20140341952A1
Human necessities

Method of treatment of diseases using hoodia extracts

#20 | 2014-09-11
US20140255420A1
Human necessities

Combination therapy of beta-glycolipids and antibodies for the treatment of immune-related disorders

#21 | 2014-09-11
US20140255403A1
Chemistry; metallurgy

ORAL COMPOSITION COMPRISING A TNF ANTAGONIST AND USE THEREOF

#22 | 2014-02-06
US20140033795A1
Human necessities

Method for detection of hepatocellar carcinoma (HCC) using an octanoate breath test

#23 | 2014-01-23
US20140024953A1
Human necessities

Breath test device and method

#24 | 2013-08-29
US20130224216A1
Human necessities

Anti-LPS enriched immunoglobulin preparation for use in treatment and/or prophylaxis of a pathologic disorder

#25 | 2013-08-08
US20130202724A1
Human necessities

SOYBEAN EXTRACTS FOR THE TREATMENT OF HEPATIC DISORDERS

#26 | 2013-06-27
US20130164302A1
Human necessities

Immuno-Modulating Compositions for the Treatment of Immune-Mediated Disorders

#27 | 2013-03-28
US20130078238A1
Human necessities

Methods and Compositions for Treating Hepatitis with Anti-CD3 Immune Molecule Therapy

#28 | 2013-01-10
US20130012549A1
Human necessities

Method for the treatment, alleviation of symptoms of, relieving, improving and preventing a cognitive disease, disorder or condition

#29 | 2012-11-01
US20120277270A1
Human necessities

Method for decreasing symptoms of alcohol consumption

#30 | 2012-10-18
US20120264781A1
Human necessities

METHOD FOR THE TREATMENT, ALLEVIATION OF SYMPTOMS OF, RELIEVING, IMPROVING AND PREVENTING A COGNITIVE DISEASE, DISORDER OR CONDITION

#31 | 2012-09-27
US20120245380A1
Human necessities

Inhibition of ornithine aminotransferase for the treatment of proliferative disorders

#32 | 2012-06-14
US20120148547A1
Human necessities

COMBINATION OF VITAMIN E AND BETA-GLYCOSPHINGOLIPIDS IN COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING HEPATIC DISORDERS

#33 | 2012-05-31
US20120135007A1
Human necessities

Anti-LPS enriched immunoglobulin preparations for the treatment and/or prophylaxis of a pathologic disorder

#34 | 2011-10-20
US20110257095A1
Human necessities

PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY

#35 | 2011-09-29
US20110236438A1
Human necessities

METHOD OF TREATMENT OF DISEASES USING HOODIA EXTRACTS

#36 | 2011-08-18
US20110200617A1
Human necessities

COMBINATION THERAPY OF BETA-GLYCOLIPIDS AND ANTIBODIES FOR THE TREATMENT OF IMMUNE-RELATED DISORDERS

#37 | 2011-08-18
US20110200610A1
Chemistry; metallurgy

Immuno-Modulating Compositions for the Treatment of Immune-Mediated Disorders

#38 | 2010-10-21
US20100268040A1
Human necessities

METHOD AND SYSTEM FOR DETECTION OF PRE-FAINTING AND OTHER CONDITIONS HAZARDOUS TO THE HEALTH OF A PATIENT

#39 | 2010-10-07
US20100256198A1
Human necessities

METHOD FOR DECREASING SYMPTOMS OF ALCOHOL CONSUMPTION

#40 | 2010-09-30
US20100249048A1
Human necessities

BETA GLYCOLIPIDS FOR THE TREATMENT OF CALCIFICATION RELATED DEGENERATIVE DISORDERS

#41 | 2010-09-30
US20100247652A1
Human necessities

Alginate biomaterials for the treatment of hepatic disorders

#42 | 2010-02-11
US20100036273A1
Human necessities

Breath test device and method

#43 | 2010-01-28
US20100021500A1
Human necessities

Processes for treating subjects carrying viral infectious agent

#44 | 2010-01-21
US20100016412A1
Human necessities

Inhibition of ornithine aminotransferase for the treatment of proliferative disorders

#45 | 2009-05-21
US20090131810A1
Human necessities

Breath test device and method

#46 | 2007-05-24
US20070117778A1
Human necessities

β glycolipids as immuno-modulators

#47 | 2005-12-15
US20050277112A1
Human necessities

Novel therapeutic processes for treating infectious agents using same epitope specific antigens, and useful compositions therefor

#48 | 2005-11-24
US20050260560A1
Human necessities

Novel therapeutic processes for treating cancer with trained or adopted immune cells, and useful compositions therefor

#49 | 2005-11-24
US20050260227A1
Human necessities

Novel therapeutic processes for treating cancer with specific antigens

#50 | 2005-11-24
US20050260226A1
Human necessities

Novel therapeutic processes for treating infectious agents by training or adoptive transfer of immune cells, and useful compositions therefor

#51 | 2005-11-17
US20050255454A1
Human necessities

Novel therapeutic processes for enhancing immunized states of vaccinated subjects

#52 | 2005-07-07
US20050147586A1
Human necessities

Therapeutic processes and useful compositions therefor

#53 | 2005-06-23
US20050136074A1
Human necessities

Novel therapeutic vaccination processes, and useful compositions therefor

#54 | 2005-06-02
US20050118196A1
Human necessities

Novel therapeutic processes for establishing or enhancing an immunized state, and compositions useful therefor

InventorID:

30137 ⎘